Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,454,344
+$408,148 QoQ
Shares Held
3,913
-3.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#178
of 422 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 8%
None 92%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Regal Investment Advisors LLC holds $10,476,569 across 7 Biotechnology names. KRYS ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
103,861 | $5,823,486 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,238 | $1,608,411 | |
| 3 | KRYS |
Krystal Biotech, Inc.
This page
|
3,913 | $1,454,344 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,432 | $732,104 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
9,366 | $535,922 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
5,709 | $268,551 | |
| 7 | VSTM |
Verastem, Inc.
|
14,071 | $53,751 |
All Filings in KRYS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,454,344 | 3,913 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,046,196 | 4,050 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,074,914 | 4,360 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $761,903 | 4,316 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $609,497 | 4,434 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $776,552 | 4,307 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||